Incyte | Fremdkapital

Aktienkurs
101.23
Täglich Wechseln
1.14 1.14%
Monatlich
0.05%
Jährlich
37.73%
Q1 Prognose
98.18




Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agenus USD 23.6M 448K 2025-09
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
BioCryst Pharmaceuticals USD 194.37M 48.43M 2025-09
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
Incyte USD 30.2M 5.17M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
MacroGenics USD 70.26M 4K 2025-09
Merck USD 39.97B 6B 2025-09
Moderna USD 610M 584M 2025-12
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 24.24B 174M 2025-09
Novartis USD 24.24B 174M 2025-09
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03


Incyte Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.